Role of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferation.
Several studies indicated that type 2 diabetes mellitus and insulin resistance are associated with increased colon cancer risk. Recently, studies suggest that metformin can reduce cancer risk in diabetic or non-diabetic patients with unclear mechanisms. This work aimed to determine the effect of met...
Guardado en:
Autores principales: | Dalia K Zaafar, Sawsan A Zaitone, Yasser M Moustafa |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dbec5b23b85d4462867ee78ee8312261 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Peroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetes
por: Cyrus V Desouza, et al.
Publicado: (2009) -
Metformin and Micronutrient Status in Type 2 Diabetes: Does Polypharmacy Involving Acid-Suppressing Medications Affect Vitamin B12 Levels?
por: Wakeman M, et al.
Publicado: (2020) -
Differences of Angiogenesis Factors in Tumor and Diabetes Mellitus
por: Tan S, et al.
Publicado: (2021) -
Involvement of PAR2 in platelet‐derived growth factor receptor‐α‐positive cell proliferation in the colon of diabetic mice
por: Yu‐Jia Li, et al.
Publicado: (2021) -
Metformin prevents stroke damage in non-diabetic female mice with chronic kidney disease
por: Maria Grissi, et al.
Publicado: (2021)